Technological advances in closed-loop drug-device delivery systems that improve patient experience and lead to clinical adoption in diabetes, oncology and neurology with representatives from Abbott, Novo Nordisk, Key Tech, Beta Bionics and MIT.
Technological advances in closed-loop drug-device delivery systems that improve patient experience and lead to clinical adoption in diabetes, oncology and neurology with representatives from Abbott, Novo Nordisk, Key Tech, Beta Bionics and MIT.